SCHEMBL6826962

SCHEMBL6826962

C1=C(OCCCCCCOC2=CCCC2)CCC1

nearest known ligand 0.33

Predicted protein targets (top 2)

geneUniProtsupporting neighboursconfidence
KCNH2 Q12809 1/20 0.33
HRH3 Q9Y5N1 1/20 0.33

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL16544487 0.91 KDM1A (0.30) KCNH2HRH3
SCHEMBL10427899 0.87 LTA4H (0.38) KCNH2HRH3
SCHEMBL9499471 0.85 LTA4H (0.35) KCNH2HRH3
SCHEMBL11124801 0.84 LTA4H (0.39)
SCHEMBL491941 0.84
SCHEMBL15092951 0.84
SCHEMBL9500775 0.82
SCHEMBL11699138 0.81 LTA4H (0.37)
SCHEMBL16548119 0.81 LOX (0.35)
SCHEMBL20703695 0.80

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 7 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-6740358-B2 Reactive coalescents ROHM AND HAAS COMPANY 2004-05-25 US disclosed
EP-1106593-B1 A composition comprising a vinyl reactive coalescent ROHM & HAAS (US) 2004-02-04 EP disclosed
EP-0870749-B1 Reactive coalescents ROHM & HAAS (US) 2003-06-25 EP disclosed
US-20020197407-A1 Reactive coalescents SPEECE DAVID GERALD (US) 2002-12-26 US disclosed
US-6451380-B1 IMPROVED STABILITY WITH INHIBITOR SELECTED FROM 4-METHOXYPHENOL, 4-HYDROXY-2,2,6,6-TETRAMETHYL-1-PIPERIDINYLOXY, 4-OXO-2,2,6,6-TETRAMETHYL- 1-PIPERIDINYLOXY, AND DI-TERTIARY BUTYL NITROXYL; EMULSION POLYMER; COATINGS ROHM AND HAAS COMPANY 2002-09-17 US disclosed
EP-1106593-A2 A composition comprising a vinyl reactive coalescent ROHM AND HAAS COMPANY (US) 2001-06-13 EP disclosed
EP-0870749-A2 Reactive coalescents ROHM AND HAAS COMPANY (US) 1998-10-14 EP disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20020197407-A1 Reactive coalescents XRCC6, RAD51, CLTA KCNH2 3695/4885HRH3 2794/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.